Barricade Therapeutics Corp.
View this filing on EDGAR (filing index, accession 0002090859-26-000003) | All Form C filings by this company on EDGAR
Filing details
| Company | Barricade Therapeutics Corp. | (Form C, issuer information) |
|---|---|---|
| State | TX | (Form C, issuer information) |
| Platform | StartEngine Primary, LLC | (Form C, issuer information) |
| Filing date | 2026-03-02 | (EDGAR filing index) |
| Date of incorporation | 2017-11-07 | (Form C, issuer information) |
| Employees | 1 | (Form C, issuer information) |
| Security offered | Other Convertible Note | (Form C, offering information) |
| Price per security | not reported | (Form C, offering information) |
| Target amount | $20,000 | (Form C, offering information) |
| Maximum ask | $1,235,000 | (Form C, offering information) |
| Offering deadline | 2026-04-30 | (Form C, offering information) |
| Platform compensation | 7 - 13 percent | (Form C, offering information) |
Financial summary
Figures are as entered by the company in the financial summary on the cover of its Form C. They are self-reported and unaudited, and they are not taken from the financial statements filed as exhibits to the Form C, which we do not read mechanically.
| Item | Most recent fiscal year | Prior fiscal year | Source |
|---|---|---|---|
| Revenue | $249,853 | $988,125 | (Form C, financial summary) |
| Cost of goods sold | $0 | $0 | (Form C, financial summary) |
| Net income | -$935,689 | -$17,008 | (Form C, financial summary) |
| Taxes paid | $0 | $0 | (Form C, financial summary) |
| Cash and equivalents | $10,832 | $493,663 | (Form C, financial summary) |
| Accounts receivable | $0 | $0 | (Form C, financial summary) |
| Total assets | $76,373 | $725,114 | (Form C, financial summary) |
| Short-term debt | $433,543 | $329,126 | (Form C, financial summary) |
| Long-term debt | $2,969,312 | $2,786,781 | (Form C, financial summary) |
Mechanical checks that fired
- Related-party language. Related-party language appears in this offering's own Form C filing or in an amendment to it, in a sentence that states it rather than ruling it out. The phrase can describe routine or unusual arrangements, so read the quoted sentence and the filing. Found in: 0002090859-26-000003, 0002090859-26-000006, 0002090859-26-000010.
"Even upon conversion of the notes, you will have limited rights in regard to the corporate actions of the Company, including additional issuances of securities, company repurchases of securities, a sale of the Company or its significant assets, or company transactions with related parties."
"Even upon conversion of the notes, you will have limited rights in regard to the corporate actions of the Company, including additional issuances of securities, company repurchases of securities, a sale of the Company or its significant assets, or company transactions with related parties."
- Net loss in both years. Net income is negative in both fiscal years reported in the Form C financial summary.
- Cash below one year of losses. Net loss for the most recent fiscal year is larger than year-end cash, both as reported in the Form C financial summary.
- Debt above assets. Short-term plus long-term debt is larger than total assets in the Form C financial summary.
- Platform compensation of 8% or more. The platform compensation stated in the Form C is 8% or more of the offering.
A check means "read this part of the filing closely." It is not a judgment about how the company will do.
Company website as listed in the Form C: https://www.barricadetherapeutics.com
Want the weekly briefing? Subscribe free.